Ypsomed Holding AG (YPHDF)

Market Cap	5.79B
Revenue (ttm)	730.51M
Net Income (ttm)	88.06M
Shares Out	n/a
EPS (ttm)	6.45
PE Ratio	65.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	74
Open	417.98
Previous Close	n/a
Day's Range	417.98 - 417.98
52-Week Range	362.00 - 496.25
Beta	1.12
RSI	65.06
Earnings Date	May 21, 2025

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1984
• Employees: 2,296
• Stock Exchange: OTCMKTS
• Ticker Symbol: YPHDF

Financial Performance

In 2023, Ypsomed Holding AG's revenue was 548.46 million, an increase of 10.25% compared to the previous year's 497.46 million. Earnings were 78.37 million, an increase of 52.83%.

Financial numbers in CHF